Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Post-translational Modifications Regulate Class IIa Histone Deacetylase (HDAC) Function in Health and Disease
Rommel A. Mathias, Amanda J. Guise, Ileana M. Cristea
Molecular & Cellular Proteomics (2015) Vol. 14, Iss. 3, pp. 456-470
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

A short guide to histone deacetylases including recent progress on class II enzymes
Suk-Youl Park, Jeong‐Sun Kim
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 2, pp. 204-212
Open Access | Times Cited: 370
Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases
James L. Richards, Yu Anne Yap, Keiran H McLeod, et al.
Clinical & Translational Immunology (2016) Vol. 5, Iss. 5
Open Access | Times Cited: 230
Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches
Md. Sahab Uddin, Abdullah Al Mamun, Badrah S. Alghamdi, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 100-120
Closed Access | Times Cited: 139
METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial–mesenchymal transition of renal tubular cells in diabetic kidney disease
Zhaoxia Xu, Keqi Jia, Hui Wang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 136
Targeting histone deacetylases for cancer therapy: Trends and challenges
Liang Tao, Fengli Wang, Reham M. Elhassan, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 6, pp. 2425-2463
Open Access | Times Cited: 86
Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential
Minlan Yuan, Biao Yang, Gerson Rothschild, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 74
A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction
Tadatoshi Sato, Shiv Kumar Verma, Christian Castro, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 75
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 620-620
Open Access | Times Cited: 14
Histone deacetylases and their inhibitors in inflammatory diseases
Sen-Yu Zhang, Liying Zhang, Ri Wen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117295-117295
Open Access | Times Cited: 13
Independent association of general and central adiposity with risk of gallstone disease: observational and genetic analyses
Min Zhang, Ye Bai, Yutong Wang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 11
Potential Epigenetic-Based Therapeutic Targets for Glioma
Lanlan Zang, Shukkoor Muhammed Kondengaden, Fengyuan Che, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 67
Recent advances in class IIa histone deacetylases research
Yodita Asfaha, Christian Schrenk, Leandro A. Alves Avelar, et al.
Bioorganic & Medicinal Chemistry (2019) Vol. 27, Iss. 22, pp. 115087-115087
Closed Access | Times Cited: 57
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
Chun Yang, Stéphane Croteau, Pierre Hardy
Cellular Oncology (2021) Vol. 44, Iss. 5, pp. 997-1017
Open Access | Times Cited: 41
HDAC4 in cancer: A multitasking platform to drive not only epigenetic modifications
Emma Cuttini, Camilla Goi, Ester Pellarin, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 17
Heat shock protein paradigms in cancer progression: future therapeutic perspectives
Y. Mohammed Tausif, Dithu Thekkekkara, Thummuru Ekshita Sai, et al.
3 Biotech (2024) Vol. 14, Iss. 4
Closed Access | Times Cited: 7
Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response
Tao Wang, Wangchao Xu, Meiling Qin, et al.
Journal of Biological Chemistry (2016) Vol. 291, Iss. 27, pp. 14373-14384
Open Access | Times Cited: 57
Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Exerts Neurotoxicity in Models of Parkinson’s Disease
Qimei Wu, Xiaoyu Yang, Lei Zhang, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 9, pp. 6970-6983
Closed Access | Times Cited: 55
Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma
Mee‐Young Ahn, Jung‐Hoon Yoon
Oncology Reports (2016) Vol. 37, Iss. 1, pp. 540-546
Open Access | Times Cited: 47
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells
Eros Di Giorgio, Emiliano Dalla, Elisa Franforte, et al.
Nucleic Acids Research (2019) Vol. 48, Iss. 2, pp. 646-664
Open Access | Times Cited: 44
Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer’s disease
Narendran Annadurai, Khushboo Agrawal, Petr Džubák, et al.
Cellular and Molecular Life Sciences (2017) Vol. 74, Iss. 22, pp. 4159-4169
Closed Access | Times Cited: 40
METTL3 stabilizes HDAC5 mRNA in an m6A-dependent manner to facilitate malignant proliferation of osteosarcoma cells
Renbing Jiang, Zhibing Dai, Junshen Wu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 22
A multi-omics analysis reveals that the lysine deacetylase ABHD14B influences glucose metabolism in mammals
Abinaya Rajendran, Amarendranath Soory, Neha Khandelwal, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 7, pp. 102128-102128
Open Access | Times Cited: 22
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function
Yuheng Jin, Xuxin Qi, Xiaoli Yu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Protective effects of ginsenoside Rd on inflammation and mitochondrial dysfunction in lipopolysaccharide-induced microglial activation through histone deacetylase 5-mediated signaling
Jimin Park, Chae Young Moon, Jinhwan Jo, et al.
Food Bioscience (2025), pp. 106248-106248
Closed Access
SIK1 promotes ferroptosis resistance in pancreatic cancer via HDAC5-STAT6-SLC7A11 axis
Hao Zhang, Tao Ma, Xiaofeng Wen, et al.
Cancer Letters (2025), pp. 217726-217726
Closed Access
Page 1 - Next Page

Scroll to top